Hetero's paediatric lopinavir/ritonavir tablet prequalified
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
On 18 May 2018, WHO has issued a web statement signalling a potential risk of neural tube defects in infants born to women who were taking dolutegravir (DTG) at the time of conception.
The ICHQ3D guideline presents a process to assess and control elemental impurities in drug products using the principles of risk assessment.
In April 2018, EMA published a report with an overview of the activities of the programme between 2011 and 2016.
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
New addition to the List of Prequalified Quality Control
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
New addition to the List of Prequalified Quality Control Laboratories (QCLs):
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
On 07 April 2017, WHO issued a position paper on the import alert placed on, Qinhuangdao Zizhu Pharmaceutical (QZP) by the United States Food and Drug Administration (USFDA) on 8 March 2017.
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Following corrective actions taken by Svizera Labs Pvt Ltd and the clarifications provided
Linezolid manufactured by Optimus Drugs Pvt Ltd has been